+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Impact of the proline residue on ligand binding of neurotensin receptor 2 (NTS2)-selective peptide-peptoid hybrids



Impact of the proline residue on ligand binding of neurotensin receptor 2 (NTS2)-selective peptide-peptoid hybrids



Chemmedchem 8(5): 772-778



To investigate the binding mode and structure-activity relationships (SARs) of selective neurotensin receptor 2 (NTS2) ligands, novel peptide-peptoid hybrids that simulate the function of the endogenous ligand were developed. Starting from our recently described NTS2 ligands of type 1, structural variants of type 2 and the metabolically stable analogues 3 a,b were developed. Replacement of the proline unit by a collection of structural surrogates and evaluation of the respective molecular probes for NTS2 affinity and selectivity indicated similar SARs as described for NT(8-13) derivatives bound to the subtype NTS1. Peptide-peptoid hybrids 2 d, 3 a,b showed substantial NTS2 binding affinity (Ki =8.1-16 nM) and 2400-8600-fold selectivity over NTS1. The thiazolidine derivative 3 b showed metabolic stability over 32 h in a serum degradation assay. In an inositol phosphate accumulation assay, the neurotensin mimetics 3 a and 3 b displayed an inhibition of constitutive activity exceeding 1.7-2.0 times the activity of NT(8-13). The fluorinated derivative 3 a could afford attractive opportunities to detect NTS2 by (19) F magnetic resonance imaging.

(PDF emailed within 0-6 h: $19.90)

Accession: 053726083

Download citation: RISBibTeXText

PMID: 23532897

DOI: 10.1002/cmdc.201300054


Related references

Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand. Chemmedchem 8(1): 75-81, 2013

Characterization of a phosphorylated peptide and peptoid and peptoid-peptide hybrids by mass spectrometry. Journal of Mass Spectrometry 37(1): 47-55, 2002

Synthesis of a (68)ga-labeled peptoid-Peptide hybrid for imaging of neurotensin receptor expression in vivo. Acs Medicinal Chemistry Letters 1(5): 224-228, 2010

Synthesis and binding characteristics of [(3)H]neuromedin N, a NTS2 receptor ligand. Neuropeptides 57: 15-20, 2015

MHC class II binding of peptoid-peptide hybrids. Immunobiology 203(1-2): 30, November, 2000

Ligand-receptor interactions at the parathyroid hormone receptors: subtype binding selectivity is mediated via an interaction between residue 23 on the ligand and residue 41 on the receptor. Molecular Pharmacology 74(3): 605-613, 2008

Identification of Shc Src homology 2 domain-binding peptoid-peptide hybrids. Journal of Medicinal Chemistry 52(6): 1612-1618, 2009

NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids. Bioorganic & Medicinal Chemistry (): -, 2016

Thermodynamics of phosphotyrosine peptide-peptoid hybrids binding to the p56lck SH2 domain. Journal of Peptide Science 16(7): 322-328, 2010

Peptoid-peptide hybrids as potent novel melanocortin receptor ligands. Journal of Medicinal Chemistry 48(13): 4224-4230, 2005

Major histocompatibility complex class II binding characteristics of peptoid-peptide hybrids. Bioorganic & Medicinal Chemistry 10(6): 1939-1945, June, 2002

Blockade of neurotensin binding the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists. Neuroendocrinology 59(6): 572-578, 1994

Non-peptide ligand binding to the formyl peptide receptor FPR2--A comparison to peptide ligand binding modes. Bioorganic & Medicinal Chemistry 23(14): 4072-4081, 2016